Key facts
- CareCall (Business/Productivity Software)’s last known valuation is $5.6M (Jan 2026).
- It has raised $350K; the latest was Early Stage VC ($350K) in Jan 2026.
- Notable investors include Tomcat Invest.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for CareCall (Business/Productivity Software)
- ·The full record, as it builds
Funding rounds
No funding rounds for CareCall (Business/Productivity Software) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CareCall (Business/Productivity Software)
Developer of call management software designed for optimal management of calls and appointments. The company's platform offers features such as appointment management, automatic confirmation of appointments, tracking real-time activity, secretariat, conversational AI, helping clients by automating repetitive tasks, improving the patient experience, and freeing time for medical teams.
- Sector
- Information Technology
- HQ
- Paris, France
- Founded
- 2024
- Employees
- 12
- Website
- carecall.ai/
- Ownership
- Privately Held (backing)
CareCall (Business/Productivity Software) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CareCall (Business/Productivity Software) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CareCall (Business/Productivity Software) in its N-PORT filings yet. We sweep new filings monthly.